Grant Projects

Prestigious Grants

IMG has been successful in obtaining various types of projects, including:

European Commission grants, including the ERC Starting Grant for early career researchers  

  • Horizon 2020, H2020 – ERC 2018-STG, 802878 FunDiT – Functional Diversity of T Cells, 2019-2023, O. Štěpánek [www]
  • Horizon 2020, H2020 INFRAEOSC-04-2018, 824087 EOSC-Life – Providing an open collaborative space for digital biology in Europe, 2019-2022, P. Bartůněk, R. Sedláček [www]
  • Horizon 2020, H2020-INFRADEV-2018-2020, 823893 EU-OPENSCREEN-DRIVE – Ensuring long-term sustainability of excellence in chemical biology within Europe and beyond, 2019-2022, P. Bartůněk [www]
  • Horizon 2020, H2020 MSCA-ITN-2019, 860002 ENHPATHY – Molecular basis of human enhanceropathies,2020-2023, M. Alberich Jordà [www]
  • Horizon 2020, H2020-101000501 – Algae4IBD – Algae4IBD – from nature to bedside – algae based bio compound for prevention and treatment of inflammation, pain and IBD, 2021-2025, D. Sedlák [www]
  • Horizont 2020, H2020-INFRADEV-2016-1-730879, 730879 INFRAFRONTIER2020 – Towards enduring mouse resources and services advancing research into human health and disease, 2017-2022, R. Sedláček [www]
  • Horizon Europe, 101046133 – ISIDORe – Integrated Services for Infectious Diseases Outbreak Research, 2021-2024, P. Bartůněk, P. Hozák, R. Sedláček
  • Horizon Europe, 101072427 – GetRadi – Gene Therapy of Rare Diseases, 2022-2026, R. Sedláček
horizon 2020 logo
erc logo

European Centre for Disease Prevention and Control – HERA Incubator

  • ECDC, Grant/2021/PHF/23776 – Enhancing Whole Genome Sequencing (WGS) and/or Reverse Transcription Polymerase Chain Reaction (RT-PCR) national infrastructures and capacities to respond to the Covid-19 pandemic in the Czech Republic, 2021-2022, M. Kolář [www]
ecdc logo

OP RDE projects

  • MEYS, CZ.02.1.01/0.0/0.0/18_046/0015861 – Infrastructure upgrade of CCP II,  2020-2022, R. Sedláček [www]
  • MEYS, CZ.02.1.01/0.0/0.0/18_046/0016045 – Upgrade of the National Infrastructure for Biological and Medical Imaging Czech-BioImaging, 2020-2022, P. Hozák [www]
  • MEYS, CZ.02.1.01/0.0/0.0/18_046/0016118 – Upgrade of the National Infrastructure for Chemical Biology, 2020-2022, P. Bartůněk [www]
  • MEYS, CZ.02.2.69/0.0/0.0/18_053/0016981 – International mobility of IMG researchers II, 2020-2022, V. Chvojková [www]
  • MEYS, CZ.02.1.01/0.0/0.0/16_019/0000785 – Centre for Tumour Ecology – Research of the cancer microenvironment supporting cancer growth and spread, 2018-2023, M. Kolář [www]
logo MŠMT a EÚ

Inter-Excellence grants

  • MEYS, LTAUSA19096 – Molecular mechanisms preventing genome damage induced by replication-transcription collisions, 2020-2022, J. Dobrovolná [www]
  • MEYS, LTAUSA19118 – Role of GIT proteins in regulation of microtubule organization in glioblastoma cells, 2020-2022, Pa. Dráber [www]
  • MEYS, LTAUSA18103 – Molecular mechanisms of nuclear structure formation, 2019-2022, D. Staněk [www]
  • MEYS, LTC19048 – Advanced correlated light and electron microscopy as a tool for studying novel nuclear structures and their impact on the gene transcription and global nuclear architecture, 2019-2022, P. Hozák [www]
  • MEYS, LTC20024 – Nuclear phosphoinositides’ landscape orchestrates gene expression, 2020-2023, P. Hozák [www]
inter excellence logo

Czech Recovery Plan – EXCELES programme

  • MEYS, LX22NPO5103 – National Institute of Virology and bacteriology (NIVB), 2022-2025, J. Hejnar
  • MEYS, LX22NPO5102 – National Cancer Institute, 2022-2025, V. Kořínek
Czech Recovery Plan